[HTML][HTML] Experimental and clinical treatment of Chagas disease: a review
PAS Junior, I Molina, SMF Murta… - The American journal …, 2017 - ncbi.nlm.nih.gov
Chagas disease (CD) is caused by the protozoan parasite Trypanosoma cruzi that infects a
broad range of triatomines and mammalian species, including man. It afflicts 8 million …
broad range of triatomines and mammalian species, including man. It afflicts 8 million …
Parasitic diseases: liposomes and polymeric nanoparticles versus lipid nanoparticles
Parasitic diseases such as malaria, leishmaniasis, and trypanosomiasis represent a
significant global burden and pose a great challenge to drug discovery and delivery …
significant global burden and pose a great challenge to drug discovery and delivery …
Review on Experimental Treatment Strategies Against Trypanosoma cruzi
AL Mazzeti, P Capelari-Oliveira, MT Bahia… - Journal of …, 2021 - Taylor & Francis
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Currently, only nitroheterocyclic nifurtimox (NFX) and benznidazole (BNZ) are …
cruzi. Currently, only nitroheterocyclic nifurtimox (NFX) and benznidazole (BNZ) are …
Road map to the treatment of neglected tropical diseases: Nanocarriers interventions
Neglected tropical disease (NTD) is a set of 20 deadliest endemic diseases which shows its
presence in most of the developing countries worldwide. Nearly 1 billion of the population …
presence in most of the developing countries worldwide. Nearly 1 billion of the population …
Therapeutical approaches under investigation for treatment of Chagas disease
Introduction: A century after its discovery, American trypanosomiasis or Chagas disease
remains a serious health problem in Latin America, where it affects around 7–8 million …
remains a serious health problem in Latin America, where it affects around 7–8 million …
Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis
MJ Morilla, EL Romero - Nanomedicine, 2015 - Taylor & Francis
Chagas disease is a neglected parasitic infection caused by the protozoan Trypanosoma
cruzi. After a mostly clinically silent acute phase, the disease becomes a lifelong chronic …
cruzi. After a mostly clinically silent acute phase, the disease becomes a lifelong chronic …
From Benznidazole to new drugs: Nanotechnology contribution in Chagas disease
DC Gomes, TS Medeiros, EL Alves Pereira… - International Journal of …, 2023 - mdpi.com
Chagas disease is a neglected tropical disease caused by the protozoan Trypanosoma
cruzi. Benznidazole and nifurtimox are the two approved drugs for their treatment, but both …
cruzi. Benznidazole and nifurtimox are the two approved drugs for their treatment, but both …
First century of chagas' disease: An overview on novel approaches to nifurtimox and benznidazole delivery systems
CJ Salomon - Journal of Pharmaceutical Sciences, 2012 - Elsevier
Hundred years after the discovery of Chagas' disease, there is a lack of effective treatment to
control this neglected disease caused by the parasite Trypanosoma cruzi. The transmission …
control this neglected disease caused by the parasite Trypanosoma cruzi. The transmission …
Nanotechnological approaches against Chagas disease
EL Romero, MJ Morilla - Advanced drug delivery reviews, 2010 - Elsevier
Over several thousand years, the flagellated Trypanosome cruzi–causative agent of Chagas
disease–developed a complex life cycle between the reduviidae vectors and its human …
disease–developed a complex life cycle between the reduviidae vectors and its human …
Advances in nanocarriers as drug delivery systems in Chagas disease
C Quijia Quezada, CS Azevedo… - International journal …, 2019 - Taylor & Francis
Chagas disease is one of the most important public health problems in Latin America due to
its high mortality and morbidity levels. There is no effective treatment for this disease since …
its high mortality and morbidity levels. There is no effective treatment for this disease since …